Search Results - "Fraser‐Browne, Carol"

Contour variation is a primary source of error when delivering post prostatectomy radiotherapy: Results of the Trans‐Tasman Radiation Oncology Group 08.03 Radiotherapy Adjuvant Versus Early Salvage (RAVES) benchmarking exercise by Cloak, Kirrily, Jameson, Michael G, Paneghel, Andrea, Wiltshire, Kirsty, Kneebone, Andrew, Pearse, Maria, Sidhom, Mark, Tang, Colin, Fraser‐Browne, Carol, Holloway, Lois C, Haworth, Annette

“…Introduction Variation in target volume delineation from clinical trial protocols has been shown to contribute to poorer patient outcomes. A clinical trial…”
Get full text

Phase 3 Trial of Domiciliary Humidification to Mitigate Acute Mucosal Toxicity During Radiation Therapy for Head-and-Neck Cancer: First Report of Trans Tasman Radiation Oncology Group (TROG) 07.03 RadioHUM Study by Macann, Andrew, FRANZCR, Fua, Tsien, FRANZCR, Milross, Chris G., MD, Porceddu, Sandro V., MD, Penniment, Michael, FRANZCR, Wratten, Chris, FRANZCR, Krawitz, Hedley, FRANZCR, Poulsen, Michael, FRANZCR, Tang, Colin I., FRANZCR, Morton, Randall P., FRACS, Hay, K. David, MDSc, Thomson, Vicki, MN, Bell, Melanie L., PhD, King, Madeleine T., PhD, Fraser-Browne, Carol L., BA, Hockey, Hans-Ulrich P., MSc

“…Purpose To assess the impact of domicile-based humidification on symptom burden during radiation therapy (RT) for head-and-neck (H&N) cancer. Methods and…”
Get full text

A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high‐risk features: background and rationale of the Radiotherapy – Adjuvant Versus Early Salvage (RAVES) trial by Pearse, Maria, Fraser‐Browne, Carol, Davis, Ian D., Duchesne, Gillian M., Fisher, Richard, Frydenberg, Mark, Haworth, Annette, Jose, Chakiath, Joseph, David J., Lim, Tee S., Matthews, John, Millar, Jeremy, Sidhom, Mark, Spry, Nigel A., Tang, Colin I., Turner, Sandra, Williams, Scott G., Wiltshire, Kirsty, Woo, Henry H., Kneebone, Andrew

“…Objectives To test the hypothesis that observation with early salvage radiotherapy (SRT) is not inferior to ‘standard’ treatment with adjuvant RT (ART) with…”
Get full text

Optimizing Radiation Therapy Quality Assurance in Clinical Trials: A TROG 08.03 RAVES Substudy by Trada, Yuvnik, MBBS, Kneebone, Andrew, FRANZCR, Paneghel, Andrea, BAppSc, Pearse, Maria, MBChB, FRANZCR, Sidhom, Mark, FRANZCR, Tang, Colin, FRANZCR, Wiltshire, Kirsty, FRANZCR, Haworth, Annette, PhD, Fraser-Browne, Carol, BA, Martin, Jarad, FRANZCR

“…Purpose To explore site- and clinician-level factors associated with protocol violations requiring real-time-review (RTR) resubmission in a multicenter…”
Get full text

Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data by Vale, Claire L, Fisher, David, Kneebone, Andrew, Parker, Christopher, Pearse, Maria, Richaud, Pierre, Sargos, Paul, Sydes, Matthew R, Brawley, Christopher, Brihoum, Meryem, Brown, Chris, Chabaud, Sylvie, Cook, Adrian, Forcat, Silvia, Fraser-Browne, Carol, Latorzeff, Igor, Parmar, Mahesh K B, Tierney, Jayne F

“…It is unclear whether adjuvant or early salvage radiotherapy following radical prostatectomy is more appropriate for men who present with localised or locally…”
Get full text

Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial by Kneebone, Andrew, Fraser-Browne, Carol, Duchesne, Gillian M, Fisher, Richard, Frydenberg, Mark, Herschtal, Alan, Williams, Scott G, Brown, Chris, Delprado, Warick, Haworth, Annette, Joseph, David J, Martin, Jarad M, Matthews, John H L, Millar, Jeremy L, Sidhom, Mark, Spry, Nigel, Tang, Colin I, Turner, Sandra, Wiltshire, Kirsty L, Woo, Henry H, Davis, Ian D, Lim, Tee S, Pearse, Maria

“…Adjuvant radiotherapy has been shown to halve the risk of biochemical progression for patients with high-risk disease after radical prostatectomy. Early…”
Get full text

Lentiviral Gene Therapy for Artemis-Deficient SCID by Cowan, Morton J., Yu, Jason, Facchino, Janelle, Fraser-Browne, Carol, Sanford, Ukina, Kawahara, Misako, Dara, Jasmeen, Long-Boyle, Janel, Oh, Jess, Chan, Wendy, Chag, Shivali, Broderick, Lori, Chellapandian, Deepak, Decaluwe, Hélène, Golski, Catherine, Hu, Diana, Kuo, Caroline Y., Miller, Holly K., Petrovic, Aleksandra, Currier, Robert, Hilton, Joan F., Punwani, Divya, Dvorak, Christopher C., Malech, Harry L., McIvor, R. Scott, Puck, Jennifer M.

“…Severe combined immunodeficiency caused by mutations in the gene encoding a DNA-repair enzyme called Artemis is difficult to treat. This study involving 10…”
Get full text

Azacitidine Administration Following Hematopoietic Stem Cell Transplantation Is Safe and Feasible in Children with Acute Leukemia by Wahlstrom, Justin T., Horn, Biljana N., Fraser-Browne, Carol, Hoeweler, Rebecca, Lu, Ying, Melton, Alexis, Willert, Jennifer, Dvorak, Christopher C.

“…Introduction High dose chemotherapy with or without radiation followed by hematopoietic stem cell transplantation (HSCT) is standard therapy for pediatric…”
Get full text

Dovitinib in first-line metastatic renal cell carcinoma and correlation of efficacy with tumor gene status: A phase II clinical trial by Broom, Reuben James, Dranitsaris, George, Fraser-Browne, Carol, Thompson, Kerin, Duffey, Steve, Wilson, Georgia, Oei, Paul, Zwi, Jonathan, McKeage, Mark James, Mitchell, Nicola Jane, Hanning, Fritha, Fong, Peter C.C.

“…Abstract only…”
Get full text

Dovitinib in first-line renal cell carcinoma: An investigation into tumour gene status and correlation with efficacy: A phase II clinical trial by Broom, Reuben James, Duffey, Steven, Fraser-Browne, Carol, Wilson, Georgia, Thompson, Kerin, Hanning, Fritha, Mitchell, Nicola Jane, Zwi, Jonathan, McKeage, Mark James, Dranitsaris, George, Oei, Paul, Fong, Peter C.C.

“…Abstract only 443 Background: Dovitinib is an anti-VEGFR tyrosine kinase inhibitor, differentiated by its inhibition of FGFR-1,-2,-3 and PDGFRβ. We evaluated…”
Get full text

A P hase III trial to investigate the timing of radiotherapy for prostate cancer with high‐risk features: background and rationale of the Radiotherapy – Adjuvant Versus Early Salvage ( RAVES ) trial by Pearse, Maria, Fraser‐Browne, Carol, Davis, Ian D., Duchesne, Gillian M., Fisher, Richard, Frydenberg, Mark, Haworth, Annette, Jose, Chakiath, Joseph, David J., Lim, Tee S., Matthews, John, Millar, Jeremy, Sidhom, Mark, Spry, Nigel A., Tang, Colin I., Turner, Sandra, Williams, Scott G., Wiltshire, Kirsty, Woo, Henry H., Kneebone, Andrew

“…Objectives To test the hypothesis that observation with early salvage radiotherapy ( SRT ) is not inferior to ‘standard’ treatment with adjuvant RT ( ART )…”
Get full text

What is optimal timing of post prostatectomy radiotherapy? Is adjuvant radiotherapy equivalent to early salvage radiotherapy? The “RAVES” phase III randomized clinical trial by Pearse, Maria, Kneebone, Andrew, Duchesne, Gillian M., Fisher, Richard, Fraser-Browne, Carol, Frydenberg, Mark, Haworth, Annette, Jose, Chakiath, Joseph, David John, Lim, Tee, Matthews, John, Millar, Jeremy, Sidhom, Mark, Spry, Nigel, Tang, Colin, Turner, Sandra, Williams, Scott G., Wiltshire, Kirsty, Woo, Henry, Davis, Ian D.

“…Abstract only TPS4690 Background: Three randomised trials have demonstrated a significant benefit of adjuvant post prostatectomy radiotherapy in patients with…”
Get full text

Early Outcome of a Phase I/II Clinical Trial (NCT03538899) of Gene-Corrected Autologous CD34+ Hematopoietic Cells and Low-Exposure Busulfan in Newly Diagnosed Patients with Artemis-Deficient Severe Combined Immunodeficiency (ART-SCID) by Cowan, Morton J., Yu, Jason, Facchino, Janelle, Chag, Shivali, Fraser-Browne, Carol, Long-Boyle, Janel, Kawahara, Misako, Sanford, Ukina, Oh, Jess, Teoh, Suan, Punwani, Divya, Dara, Jasmeen, Dvorak, Christopher C., Broderick, Lori, Hu, Diana, Miller, Holly K., Petrovic, Aleksandra, Malech, Harry L., McIvor, R. Scott, Puck, Jennifer

“…ART-SCID represents ∼3% of all SCID, but occurs in 1/2000 births in Athabascan-speaking Native Americans. Artemis protein, encoded by DCLRE1C, is essential for…”
Get full text